Brain cancer is a terrible illness that doctors and scientists have struggled to treat effectively. One particularly aggressive type of brain cancer is called glioma.
People who get diagnosed with glioma usually don’t live for very long—just over a year on average—even with the best treatments we currently have like chemotherapy and radiation.
That’s why new research from the University of Michigan is such a big deal; it offers new hope for extending the lives of people with glioma.
The Experiment: A Mix of Drugs for a Powerful Effect
The research was led by Pedro Lowenstein and Maria Castro, experts in brain science and cancer studies.
They decided to try something different. Instead of using just one kind of treatment, they mixed two types together.
The first part of the treatment uses a special protein called HSV-1-TK along with a common drug called Valtrex, which you might know as a treatment for cold sores. When they are mixed, they create a powerful substance that can kill cancer cells.
The second part uses another protein, called Flt3L. This protein’s job is to attract immune cells to the brain. These immune cells help the body fight the cancer more effectively.
The combination of these two treatments had amazing early results. Out of 18 patients in the study, six lived for more than two years, three lived for more than three years, and one is still alive after five years.
This is far longer than the usual 14-month life expectancy for glioma patients.
What’s Next: The Future of this Treatment
One of the best things about this new treatment is that it didn’t make the patients sick, which means the highest dose of the drugs used in this experiment could be used in future studies.
Plus, the researchers found out something surprising: the treatment stayed active in the body for much longer than expected, up to 17 months.
This is great because it means the treatment could potentially keep working for a long time to stop the cancer from coming back.
But it’s important to note that this is still early research. More studies will have to be done to make sure the treatment is safe and effective for more people.
However, the results are really promising and could be the basis for better treatments in the future.
Wrapping Up
Doctors are always trying to find better ways to treat illnesses, and cancer is one of the toughest enemies. But this new study gives us hope.
It shows that a mix of two treatments could help people with an aggressive form of brain cancer live longer. While there’s still a lot more work to do, it’s an exciting step forward in the fight against cancer.
If you care about cancer, please read studies about common drugs for inflammation may help kill cancer, and statin drugs can starve cancer cells to death.
For more information about cancer, please see recent studies about these two things are key to surviving cancer and results showing common Indian fruit may slow down cancer growth.
The study was published in The Lancet Oncology.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
